IntrinsicIntrinsic
← Scroll for more →

Financial Statements — HNGE

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Cash & Equivalents0.290.190.210.260.24
Short-term Investments------0.220.18
Accounts Receivable0.130.110.070.090.10
Inventory0.020.010.020.010.01
Total Current Assets0.640.540.530.660.60
Property, Plant & Equipment0.010.010.010.010.01
Goodwill0.060.060.060.060.06
Intangible Assets0.000.000.000.000.00
Total Non-current Assets0.020.020.020.020.02
Total Assets0.830.730.740.770.69
Accounts Payable0.060.070.060.050.03
Total Current Liabilities0.480.410.360.360.31
Total Non-current Liabilities*0.000.000.000.000.01
Total Liabilities0.480.420.370.360.32
Retained Earnings(0.97)(1.02)(1.05)(1.08)(1.08)
Total Stockholder Equity0.340.110.180.210.17
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Total Revenue212.82182.31170.73154.21139.10
Cost of Revenue28.8728.0726.7028.0141.34
Gross Profit183.95154.23144.03126.2097.76
Research & Development34.0630.3432.7631.92279.96
Selling, General & Admin28.0423.0224.5336.85251.24
Total Operating Expenses143.51122.16116.77132.29678.43
Operating Income40.4432.0727.26(6.09)(580.67)
Pretax Income44.4335.9432.22(1.64)(575.98)
Tax Provision0.740.810.120.21(0.33)
Net Income43.6935.1332.10(1.84)(575.65)
Basic EPS0.550.432.11(0.02)(13.10)
Diluted EPS0.520.412.11(0.02)(13.10)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Operating Cash Flow101.4143.0863.8982.4025.15
Capital Expenditures0.120.080.410.050.25
Free Cash Flow*101.2943.0063.4982.3524.90
Investing Cash Flow28.6248.08(37.70)(58.76)(17.31)
Financing Cash Flow(30.48)(112.85)(79.54)0.53(71.45)
← Scroll for more columns →

* Derived from reported values